Zuomei Li

Zuomei Li is an experienced professional with a diverse background in the pharmaceutical industry. They currently work as an Independent Consultant, providing expertise in their field. Prior to this, Li held leadership positions at NuChem Sciences and NuChem Therapeutics Inc. as Senior Director and Director, respectively, focusing on cell biology. They also founded Amplia PharmaTek Inc., where they served as the Director of Cell Biology and in vivo Pharmacology, providing drug discovery services to biotechnology companies and academic investigators. Earlier in their career, Li worked at Methylgene Inc., where they held the role of Executive Director of Molecular Biology. In this role, Li contributed to various aspects of preclinical drug discovery, including target validation, assay development, and translational studies in early clinical trials. They were also involved in strategic planning, budgeting, and collaborative work with external partners. Overall, Li has significant experience and expertise in their field, with numerous publications and patents to their name.

Zuomei Li completed a Bachelor of Science degree in Biochemistry from Sichuan University in the years 1982 to 1986. Following that, from 1988 to 1994, Li pursued a Ph.D. in Biochemistry from the University of Toronto. Li then attended the University of California, Los Angeles from 1994 to 1998, though it is not specified what degree or field of study was pursued during that time.